Featured Jobs
Bates & Company
|
Retirement Plan Documents Specialist Loren D. Stark Company
|
Retirement, LLC
|
Pentegra
|
Retirement, LLC
|
Jr Retirement Plan Administrator/ Administrative Assistant Hochheiser Deutsch & Co, Inc.
|
Carpenter Morse Group
|
Employee Benefits and Executive Compensation Associate Attorney Verrill
|
Trucker Huss, A Professional Corporation
|
Retirement Plan Administrator (TPA) Retirement Plan Consultants
|
Compass Retirement Consulting Group, Inc.
|
Retirement Plan Legal Specialist Pentegra
|
Retirement Plan Relationship Manager ERISA Services, Inc.
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
 |    |
<< Previous news item | Next news item >>
| Thinking About Drug Price Controls Steven Pearlstein in The Washington Post; subscription may be required  May 27, 2004 Excerpt: Washington Post columnist Steven Pearlstein was online to talk about whether the government should study the cost-effectiveness of new medicines and then use that information to determine how much Medicare should pay drugmakers. In his column today, Pearlstein concludes: 'The question isn't whether we'll ration and manage, but who will do it and how. And sooner we start talking about it openly, the better things will turn out.' |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above). |
| An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified). |
